| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-10 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-10 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
9e-10 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-09 |
| mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-09 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-09 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-09 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-08 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-08 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-08 |